Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions,
polymeric nanoparticles and many others demonstrate a broad variety of useful properties …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, and polymeric
nanoparticles, demonstrate a broad variety of useful properties, such as longevity in the …

Abstract Development of highly engineered and tailor-made pharmaceutical nanocarriers
with multifunctional properties is presently under consideration for modified drug delivery …

Introduction Nanocarrier-based delivery systems offer multiple benefits to overcome
limitations of the traditional drug dosage forms, such as protection of the drug, enhanced …

The use of nanotechnology in targeted drug delivery systems (DDS) is the subject of
extensive investigations due to limitations associated with traditional forms of drug delivery …

The use of nanoparticulate pharmaceutical carriers to enhance the in vivo efficiency of many
drugs and drug administration protocols well established itself over the past decade both in …

The first closed bilayer phospholipid systems, called liposomes, were described in 1965 and
soon were proposed as drug delivery systems. The pioneering work of countless liposome …

Cancer accounts for millions of deaths every year and, due to the increase and aging of the
world population, the number of new diagnosed cases is continuously rising. Although many …

Nanotechnology has already started to significantly impact many industries and scientific
fields including biotechnology, pharmaceutics, food technology and semiconductors …

Polymeric nanomaterials have become a prominent area of research in the field of drug
delivery. Their application in nanomedicine can improve bioavailability, pharmacokinetics …